Alzheimer's disease is a neurodegenerative disease characterized by a progressive decline in mental functions and memory loss. Along with frontotemporal dementia and some other neurodegenerative ...

Many people living with dementia never receive an accurate diagnosis, in part because Alzheimer's disease, Parkinson's disease and related conditions are notoriously difficult to tell apart and often ...

For the first time, researchers found blood biomarkers for Alzheimer's disease that correlated with minor cognitive ...

More than 520,000 Britons have Alzheimer's - the most common form of dementia, which is the leading cause of death in UK.

Figuring out how advanced a patient’s Alzheimer’s disease has become could be made much easier with this method.

BD-pTau 217 is a refined biomarker which enhances Alzheimer’s specificity while retaining the strengths of plasma pTau 217.

Studying middle-aged populations is important to understanding what Alzheimer’s disease looks like in the earliest stages, to ...

When you think of Alzheimer's disease, an older person probably comes to mind; however, it can occur in people younger than 50. Our expert explains.

A new brain imaging test can detect a key hallmark of Alzheimer's disease before symptoms appear and earlier than the method currently used in clinical practice in the United States and Europe, report ...

Obesity may worsen Alzheimer’s disease through fat molecules that send harmful signals to the brain, but targeting those molecules could offer a new path for intervention.

Bruce Willis‘ wife, Emma Heming Willis, has shared an update on the movie star amid his struggle with Frontotemporal Dementia ...